See All Slides - tctmd.com

Slides

Presentation TCT 2013

Cardiogenic Shock and Hemodynamic Collapse: From Circulatory Support to Hypothermia

Presenter: Michael Mooney

October 31, 2013

Presentation TCT 2013

New Interventional Stroke Trials: THERAPY, POSITIVE, IMS4, and Others

Presenter: Alexander Khalessi

October 31, 2013

Presentation TCT 2013

Case 2: Management of Symptomatic Radial Artery Occlusion

Presenter: Samir Pancholy

October 31, 2013

Presentation TCT 2013

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Presenter: Giuseppe De Luca

October 31, 2013

Presentation

Pharmacology in High-Risk PCI: Focus on Clinical Outcomes

Presenter: C. Michael Gibson

October 31, 2013

Presentation TCT 2013

How Would I Treat this Patient?(9)

Presenter: Branko Beleslin

October 31, 2013

Presentation TCT 2013

MRI Catheterization: Ready for Primetime?

Presenter: Robert Lederman

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Advertisement

Slides

Cardiogenic Shock and Hemodynamic Collapse: From Circulatory Support to Hypothermia

New Interventional Stroke Trials: THERAPY, POSITIVE, IMS4, and Others

Case 2: Management of Symptomatic Radial Artery Occlusion

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Pharmacology in High-Risk PCI: Focus on Clinical Outcomes

How Would I Treat this Patient?(9)

MRI Catheterization: Ready for Primetime?

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content